Persistent URL of this record https://hdl.handle.net/1887/3720877
Documents
-
- Download
- clinical_relevance_of_high_plasma_trough_levels_of.9
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Clinical relevance of high plasma trough levels of the kinase inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC patients
- All authors
- Lin, L.S.; Barkman, H.J.; Smit, E.F.; Langen, A.J. de; Steeghs, N.; Beijnen, J.H.; Huitema, A.D.R.
- Date
- 2024-02-01
- Journal
- Therapeutic Drug Monitoring
- Volume
- 46
- Issue
- 1
- Pages
- 73 - 79